Vimarsana
Biggest News Aggregation in the World

Deeming Rule News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deeming Rule. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deeming Rule Today - Breaking & Trending Today

What's at Stake for the Premium Cigar Industry as DC Circuit Considers FDA Appeal? | Troutman Pepper - Vimarsana News

What's at Stake for the Premium Cigar Industry as DC Circuit Considers FDA Appeal? | Troutman Pepper

In August 2023, Judge Amit P. Mehta of the U.S. District Court for the District of Columbia partially vacated a Food and Drug Administration (FDA) rule that had “deemed” premium cigars...

Federal Judge Delivers Big Win to the Premium Cigar Industry - Vimarsana News

Federal Judge Delivers Big Win to the Premium Cigar Industry

On August 9, a judge in the District Court of D.C. issued a ruling that vacates the “deeming rule” that subjected premium cigars to the same regulations the agency uses on cigarettes. In s...

Federal Court Vacates FDA Deeming of Premium Cigars Subject to the Tobacco Control Act - Vimarsana News

Federal Court Vacates FDA Deeming of Premium Cigars Subject to the Tobacco Control Act

On August 9, 2023, Judge AMIT P. Mehta of the U.S. District Court of the District of Columbia issued a final Memorandum Opinion in Cigar Association…

Reagan-Udall Evaluation Of FDA's Center for Tobacco Products - Vimarsana News

Reagan-Udall Evaluation Of FDA's Center for Tobacco Products

Reagan-Udall Report of Center for Tobacco Products, notes that CTP’s role is not only protection via regulation but also via educating the public, especially young people. CTP is initiating the development of a comprehensive 5-year strategic plan.

Magellan Sues FDA Over Vape Registration Petition Denials - Vimarsana News

Magellan Sues FDA Over Vape Registration Petition Denials

Magellan Technology, Inc. and Vapor Train 2 LLC filed a complaint against the Food and Drug Administration (FDA) for unjustly denying Magellan’s twelve